Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Intercure Ltd. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 15 | −6 |
| Shares | 4.85M | 2.95M | −1.90M (−39.2%) |
| Value | $21.9M | $9.75M | −$12.1M (−55.4%) |
New holders (1)
Institutions that held Intercure Ltd. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Toronto Dominion Bank | 198 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Intercure Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ETF Managers Group, LLC | 1,851,339 | $8.35M |
| Cambria Investment Management, L.P. | 62,966 | $284.0K |
| Balyasny Asset Management LLC | 51,576 | $233.0K |
| ExodusPoint Capital Management, LP | 48,089 | $216.0K |
| Tower Research Capital LLC (TRC) | 744 | $3.00K |
| Sugarloaf Wealth Management, LLC | 200 | $1.00K |
| Citigroup Inc | 36 | $0 |